HLS Therapeutics Inc.
Profile
Mailing Address: 10 Carlson Court
Suite 701
Etobicoke, Ontario
M9W6L2
Head Office Address: 10 Carlson Court
Suite 701
Etobicoke, Ontario
M9W6L2
Contact Name: Ryan C. Lennox, General Counsel Principal Regulator: Ontario
Business e-mail address: r.lennox@hlstherapeutics.com Short Form Prospectus Issuer: Yes
Telephone Number: 647 495-9000 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland, North West Territories, Yukon, Nunavut
Fax Number: Stock Exchange: TSX Venture
Date of Formation: Mar 12 2018 Stock Symbol: HLS
Jurisdiction Where Formed: Ontario Auditor: Ernst & Young LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 40390B Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $100,000,001 to $500,000,000


View This Company's Documents